| 000 | 01287 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513042043.0 | ||
| 264 | 0 | _c19950608 | |
| 008 | 199506s 0 0 eng d | ||
| 022 | _a0041-1132 | ||
| 024 | 7 |
_a10.1046/j.1537-2995.1995.35595259154.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMohandas, K | |
| 245 | 0 | 0 |
_aTransfusion requirements, risks, and costs for patients with malignancy. _h[electronic resource] |
| 260 |
_bTransfusion _cMay 1995 |
||
| 300 |
_a427-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnemia _xetiology |
| 650 | 0 | 4 |
_aBlood Transfusion _xeconomics |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aErythropoietin _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTransfusion Reaction |
| 700 | 1 | _aAledort, L | |
| 773 | 0 |
_tTransfusion _gvol. 35 _gno. 5 _gp. 427-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1537-2995.1995.35595259154.x _zAvailable from publisher's website |
| 999 |
_c7739984 _d7739984 |
||